Deficiency of mannan-binding lectin associated serine protease-2 due to missense polymorphisms

Genes and Immunity

Volumn 8, Issue 2, 2007, Pages 154-163

  Thiel, S ^a   Steffensen, R ^b   Christensen, I J ^c   Ip, W K ^d   Lau, Y L ^d   Reason, I J M ^e   Eiberg, H ^f   Gadjeva, M ^a   Ruseva, M ^a   Jensenius, J C ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

^c HVIDOVRE HOSPITAL   (Denmark)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

^e FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^f UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE 2; UNCLASSIFIED DRUG;

AMERICAN INDIAN; ARTICLE; BRAZIL; CAUCASIAN; CHINESE; CONTROLLED STUDY; DENMARK; ENZYME DEFICIENCY; ESKIMO; ETHNIC DIFFERENCE; EXON; GENE DUPLICATION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GREENLAND; HOMOZYGOSITY; HONG KONG; HUMAN; MISSENSE MUTATION; PRIORITY JOURNAL; PROTEIN FUNCTION; TANDEM REPEAT; ZAMBIA;

AFRICAN CONTINENTAL ANCESTRY GROUP; ASIAN CONTINENTAL ANCESTRY GROUP; BRAZIL; DNA PRIMERS; EXONS; GENE FREQUENCY; GENOTYPE; GREENLAND; HONG KONG; HUMANS; INDIANS, SOUTH AMERICAN; INUITS; MANNOSE-BINDING PROTEIN-ASSOCIATED SERINE PROTEASES; MUTATION, MISSENSE; POLYMORPHISM, GENETIC; SEQUENCE ANALYSIS, DNA; ZAMBIA;

EID: 33847771446     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/sj.gene.6364373     Document Type: Article

References (41)

1. Hargreaves DC, Medzhitov R. Innate sensors of microbial infection. J Clin Immunol 2005; 25: 503-510.
2. Staros EB. Innate immunitynew approaches to understanding its clinical significance. Am J Clin Pathol 2005; 123: 305-312.
3. Hoffmann JA, Kafatos FC, Janeway CA, Ezekowitz RA. Phylogenetic perspectives in innate immunity. Science 1999; 284: 1313-1318.
4. Holmskov U, Thiel S, Jensenius JC. Collectins and ficolins: Humoral lectins of the innate immune defense. Annu Rev Immunol 2003; 21: 547-578.
5. Matsushita M, Fujita T. Ficolins and the lectin complement pathway. Immunol Rev 2001; 180: 78-85.
6. Weis WI, Drickamer K, Hendrickson WA. Structure of a C-type mannose-binding protein complexed with an oligosaccharide. Nature 1992; 360: 127-134.
7. Matsushita M, Endo Y, Taira S, Sato Y, Fujita T, Ichikawa N et al. A novel human serum lectin with collagen- and fibrinogenlike domains that functions as an opsonin. J Biol Chem 1996; 271: 2448-2454.
8. Le Y, Lee SH, Kon OL, Lu J. Human L-ficolin: Plasma levels, sugar specificity, and assignment of its lectin activity to the fibrinogen-like (FBG) domain. FEBS Lett 1998; 425: 367-370.
9. Krarup A, Thiel S, Hansen A, Fujita T, Jensenius JC. L-ficolin is a pattern recognition molecule specific for acetyl groups. J Biol Chem 2004; 279: 47513-47519.
10. Matsushita M, Fujita T. Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease. J Exp Med 1992; 176: 1497-1502.
11. Thiel S, Vorup-Jensen T, Stover CM, Schwaeble W, Laursen SB, Poulsen K et al. A second serine protease associated with mannan-binding lectin that activates complement. Nature 1997; 386: 506-510.
12. Dahl MR, Thiel S, Matsushita M, Fujita T, Willis AW, Christensen T et al. MASP-3 and its association with distinct complexes of the mannan-binding lectin complement activation pathway. Immunity 2001; 15: 127-135.
13. Sorensen R, Thiel S, Jensenius JC. Mannan-binding-lectin-associated serine proteases, characteristics and disease associations. Springer Semin Immunopathol 2005; 27: 299-319.
14. Walport MJ. Complement First of two parts. N Engl J Med 2001; 344: 1058-1066.
15. Walport MJ. Complement second of two parts. N Engl J Med 2001; 344: 1140-1144.
16. Garred P, Larsen F, Seyfarth J, Fujita T, Madsen HO. Mannose-binding lectin and its genetic variants. Genes Immun 2006; 7: 85-94.
17. Super M, Thiel S, Lu J, Levinsky RJ, Turner MW. Association of low levels of mannan-binding protein with a common defect of opsonisation. Lancet 1989; 2: 1236-1239.
18. Worthley DL, Bardy PG, Mullighan CG. Mannose-binding lectin: Biology and clinical implications. Intern Med J 2005; 35: 548-555.
19. Thiel S, Frederiksen PD, Jensenius JC. Clinical manifestations of mannan-binding lectin deficiency. Mol Immunol 2006; 43: 86-96.
20. Stengaard-Pedersen K, Thiel S, Gadjeva M, Moller-Kristensen M, Sorensen R, Jensen LT et al. Inherited deficiency of mannan-binding lectin-associated serine protease-2. N Engl J Med 2003; 349: 554-560.
21. Lozano F, Suarez B, Munoz A, Jensenius JC, Mensa J, Vives J et al. Novel MASP2 variants detected among North African and Sub-Saharan individuals. Tissue Antigens 2005; 66: 131-135.
22. Stover C, Endo Y, Takahashi M, Lynch NJ, Constantinescu C, Vorup-Jensen T et al. The human gene for mannan-binding lectin-associated serine protease-2 (MASP-2), the effector component of the lectin route of complement activation, is part of a tightly linked gene cluster on chromosome 1p362-3. Genes Immun 2001; 2: 119-127.
23. Moller-Kristensen M, Jensenius JC, Jensen L, Thielens N, Rossi V, Arlaud G et al. Levels of mannan-binding lectin-associated serine protease-2 in healthy individuals. J Immunol Methods 2003; 282: 159-167.
24. Carlsson M, Sjoholm AG, Eriksson L, Thiel S, Jensenius JC, Segelmark M et al. Deficiency of the mannan-binding lectin pathway of complement and poor outcome in cystic fibrosis: Bacterial colonization may be decisive for a relationship. Clin Exp Immunol 2005; 139: 306-313.
25. Stover C, Barrett S, Lynch NJ, Barker JN, Burden D, Trembath R et al. Functional MASP2 single nucleotide polymorphism plays no role in psoriasis. Br J Dermatol 2005; 152: 1313-1315.
26. Cedzynski M, Szemraj J, Swierzko AS, Bak-Romaniszyn L, Banasik M, Zeman K et al. Mannan-binding lectin insufficiency in children with recurrent infections of the respiratory system. Clin Exp Immunol 2004; 136: 304-311.
27. Olesen HV, Jensenius JC, Steffensen R, Thiel S, Schiøtz PO. The mannan-binding lectin pathway and lung disease in cystic fibrosis - dysfunction of mannan-binding-lectin-associated serine protease 2 (MASP-2) may be a major modifier. Clin Immunol 2006; 121: 324-331.
28. García-Laorden MI, García-Saavedra A, Rodríguez de Castro F, Violán JS, Rajas O, Blanquer J et al. Low clinical penetrance of mannose-binding lectin-associated serine protease 2 deficiency. J Allergy Clin Immunol 2006; 118: 1383-1386.
29. Grunnet N, Steffensen R, Jersild C. Increased frequency of HLA-DRw14b(w6)-associated RFLP in Greenlanders of Eskimo origin. Tissue Antigen 1991; 373: 127-129.
30. Helgason A, Palsson G, Pedersen HS, Angulalik E, Gunnarsdottir ED, Yngvadottir B et al. mtDNA variation in Inuit populations of Greenland and Canada: Migration history and population structure. Am J Phys Anthropol 2006; 130: 123-134.
31. Ip WK, Chan KH, Law HK, Tso GH, Kong EK,Wong WH et al. Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection. J Infect Dis 2005; 191: 1697-1704.
32. Garred P, Madsen HO, Marquart H, Hansen TM, Sorensen SF, Petersen J et al. Two edged role of mannose binding lectin in rheumatoid arthritis: A cross sectional study. J Rheumatol 2000; 27: 26-34.
33. Aggarwal BB. Signalling pathways of the TNF superfamily: A double-edged sword. Nat Rev Immunol 2003; 3: 745-756.
34. Wallis R, Dodd RB. Interaction of mannose-binding protein with associated serine proteases: Effects of naturally occurring mutations. J Biol Chem 2000; 275: 30962-30969.
35. Thielens NM, Cseh S, Thiel S, Vorup-Jensen T, Rossi V, Jensenius JC et al. Interaction properties of human mannan-binding lectin (MBL)-associated serine proteases-1 and -2, MBL-associated protein 19, and MBL. J Immunol 2001; 166: 5068-5077.
36. Stover CM, Thiel S, Thelen M, Lynch NJ, Vorup-Jensen T, Jensenius JC et al. Two constituents of the initiation complex of the mannan-binding lectin activation pathway of complement are encoded by a single structural gene. J Immunol 1999; 162: 3481-3490.
37. Gregory LA, Thielens NM, Matsushita M, Sorensen R, Arlaud GJ, Fontecilla-Camps JC et al. The X-ray structure of human mannan-binding lectin-associated protein 19 (MAp19) and its interaction site with mannan-binding lectin and L-ficolin. J Biol Chem 2004; 279: 29391-29397.
38. Gal P, Harmat V, Kocsis A, Bian T, Barna L, Ambrus G et al. A true autoactivating enzyme Structural insight into mannose-binding lectin-associated serine protease-2 activations. J Biol Chem 2005; 280: 33435-33444.
39. Weg-Remers S, Brenden M, Schwarz E, Witzel K, Schneider PM, Guerra LK et al. Major histocompatibility complex (MHC) class III genetics in two Amerindian tribes from southern Brazil: The Kaingang and the Guarani. Hum Genet 1997; 100: 548-556.
40. Eiberg H, Nielsen IM. Linkage studies of Cholestasis familiaris Groenlandica/Byler-like disease, with polymorphic protein and blood group markers. Human Heredity 1993; 43: 250-256.
41. Thiel S, Møller-Kristensen M, Jensen L, Jensenius JC. Assays for the functional activity of the mannan-binding lectin pathway of complement activation. Immunobiology 2002; 205: 446-454.